BryanJamesTraughberMD(He/Him)

Radiation Oncology • Rochester, MN

Urologic Cancer

Radiation Oncologist; Innovation Director

Join to view full profile

Dr. Traughber is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Traughber's full profile

Already have an account?

Office
200 1st Street SW
Rochester, MN 55905

Summary

I am a radiation oncologist at Mayo Clinic in Rochester, MN with subspecialty expertise in genitourinary malignancies and cardiac conditions. Additionally, I lead the departmental innovation initiatives, which include business development, industry partnerships, strategy, invention, and commercialization activities. I actively participate in translational research as it pertains to new medical devices, SAMD, AI in RT, and adaptive radiotherapy. I also contribute to the clinical trial portfolio through participation in investigator-initiated trials (IITs) and Cooperative Group Clinical Trials. I have a strong track record of success with invention, investing, and entrepreneurship in both private and public funding.

Education & Training

Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Radiation Oncology, 2012 - 2016
University Hospitals Cleveland Medical CenterPost-Doctoral Fellowship, 2010 - 2012
Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Radiology-Diagnostic, 2009 - 2010
The MetroHealth System/Case Western Reserve UniversityResidency, Internal Medicine, 2008 - 2009
David Geffen School of Medicine at UCLAClass of 2008
NIH Clinical CenterPost-Doctoral Fellowship, 2005 - 2007
Wartburg CollegeB.A., Chemistry, Biochemistry, 1997 - 2001

Certifications & Licensure

MN State Medical License 2022 - 2025
OH State Medical License 2016 - 2025
WI State Medical License 2023 - 2025
PA State Medical License 2020 - 2024
American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

Chief Resident, Radiation Oncology Case Western Reserve University School of Medicine, 2015
Roentgen Resident Research Award Radiologlical Society of North America (RSNA), 2013, 2016

Clinical Trials

Radiosurgery in Treating Patients With Kidney Tumors Start of enrollment: 2007 Feb 20
Completed
Not Applicable
PET-MRI in Diagnosing Patients With Cancer, Cardiac Diseases, or Neurologic Diseases Start of enrollment: 2013 Mar 07
Completed
Not Applicable
Magnetic Resonance Guided Focal Stereotactic Body Radiation Therapy for Localized Prostate Cancer Start of enrollment: 2016 Feb 16
Completed
Not Applicable
Pilot Study Evaluating the Role of Histopathology Correlation in Treatment Planning Start of enrollment: 2016 Jul 21
Completed
Not Applicable
Stereotactic Body Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Stage IIA-B Prostate Cancer Start of enrollment: 2017 Nov 16
Active, not recruiting
Phase 3
Enhancing SUV Accuracy of PET/MR for Clinical Trial Qualification Start of enrollment: 2019 Jun 17
Completed
Chemoradiotherapy With or Without Atezolizumab in Treating Patients With Localized Muscle Invasive Bladder Cancer Start of enrollment: 2019 Jun 03
Active, not recruiting
Phase 3
A Study of Salvage Radiotherapy With or Without Enzalutamide in Recurrent Prostate Cancer Following Surgery Start of enrollment: 2019 Apr 15
Active, not recruiting
Phase 2
Prostatic Urethral Lift (PUL) Pre-/Post-Radiation Treatment for Prostate Cancer Start of enrollment: 2019 Dec 01
Withdrawn
Not Applicable
Post Market Clinical Follow-up Study Venezia Start of enrollment: 2019 Apr 10
Completed
Niraparib With Standard Combination Radiation Therapy and Androgen Deprivation Therapy in Treating Patients With High Risk Prostate Cancer Start of enrollment: 2019 Jun 03
Suspended
Phase 2
Testing the Addition of the Drug Apalutamide to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer Start of enrollment: 2020 Mar 05
Recruiting
Phase 3
A Study of Chemotherapy and Radiation Therapy Compared to Chemotherapy and Radiation Therapy Plus MEDI4736 (Durvalumab) Immunotherapy for Bladder Cancer Which Has Spread to the Lymph Nodes (The INSPIRE Study) Start of enrollment: 2021 Mar 17
Active, not recruiting
Phase 2
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging Start of enrollment: 2020 Oct 08
Recruiting
Phase 3
Testing the Addition of Darolutamide to Hormonal Therapy (Androgen Deprivation Therapy [ADT]) After Surgery for Men With High-Risk Prostate Cancer, The ERADICATE Study Start of enrollment: 2021 Mar 01
Active, not recruiting
Phase 3
Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT Trial Start of enrollment: 2020 Dec 15
Recruiting
Phase 3
Daily Adaptive Post-Prostatectomy With Stereotactic Ablative Radiotherapy in Patients With Prostate Cancer Start of enrollment: 2023 Jul 28
Active, not recruiting
Not Applicable
Evaluation of the Impact of Empty Versus Full Bladder in Patients With Prostate Cancer, RELIEF Trial Start of enrollment: 2023 Sep 19
Recruiting
Not Applicable
A Multi-Center Trial of Androgen Suppression With Abiraterone Acetate, Leuprolide, PARP Inhibition and Stereotactic Body Radiotherapy in Prostate Cancer Start of enrollment: 2020 Nov 06
Recruiting
Phase 1, Phase 2
Evaluating Changes in Quality of Life After Near Margin-less Adaptive Radiation Therapy Compared to Standard Stereotactic Ablative Body Radiotherapy in Localized Prostate Cancer Start of enrollment: 2024 May 01
Not yet recruiting
Not Applicable
An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC. Start of enrollment: 2024 Mar 12
Recruiting
Phase 3
Radiation Therapy (Hypofractionated Proton Beam Therapy or IMRT) for the Treatment of Recurrent, Oligometastatic Prostate Cancer Following Primary Localized Treatment Start of enrollment: 2020 Jan 06
Active, not recruiting
Phase 2
Join now to see all

Publications & Presentations

PubMed

38 citations
Generation of brain pseudo-CTs using an undersampled, single-acquisition UTE-mDixon pulse sequence and unsupervised clustering
Kuan-Hao Su, Lingzhi Hu, Christian Stehning, Michael Helle, Pengjiang Qian
Medical Physics. 2015-08-01
322 citations
Pulsed-high intensity focused ultrasound and low temperature-sensitive liposomes for enhanced targeted drug delivery and antitumor effect.
Sergio Dromi, Victor Frenkel, Alfred Chun Shui Luk, Bryan Traughber, Mary Angstadt
Clinical Cancer Research. 2007-05-01
168 citations
Radiofrequency ablation induces antigen-presenting cell infiltration and amplification of weak tumor-induced immunity
Sergio Dromi, Meghaan P. Walsh, Sarah Herby, Bryan Traughber, Jianwu Xie
Radiology. 2009-04-01

Press Mentions

Husband-and-Wife Team Bring Expertise to MR-Guided Radiotherapy ProgramOctober 6th, 2021
Ohio Clinic Adopts New Solution for Treating Women with Cervical CancerNovember 7th, 2017
University Hospitals Seidman Cancer Center Launches Use of Elekta’s Venezia Gynecological Applicator for Patients with Advanced Cervical CancerAugust 8th, 2017
Join now to see all

Grant Support

Exploring SGLTs as Theranostic Targets for Cancer MetastasisNational Institutes of Health2023–2024
ACCURATE MR-BASED PET ATTENUATION CORRECTION FOR QUANTITATIVE CLINICAL TRIALSNational Institutes of Health2015–2020
IMPROVING OUTCOMES FOR MECHANICALLY VENTILATED PATIENTS WITH THE DIGITAL EZ BOARDNational Institutes of Health2015–2017
ADVANCING PATIENT CALL LIGHT SYSTEMS TO ACHIEVE BETTER OUTCOMESNational Institutes of Health2012–2014
IMPROVING OUTCOMES FOR MECHANICALLY VENTILATED PATIENTS WITH THE DIGITAL EZ BOARDNational Institutes of Health2012–2013
ADVANCING PATIENT CALL LIGHT SYSTEMS TO ACHIEVE BETTER OUTCOMESNational Institutes of Health2010–2011

Committees

Member, RTOG Foundation Communications Committee 2022 - Present
Member, NRG Oncology 2020 - Present
Radiation Committee, ECOG-ACRIN Cancer Research Group 2017 - Present
Robotic Brachytherapy Committee Member, American Association of Physicists in Medicine (AAPM) 2017 - Present
Committee Member, Radiation Safety Committee, Louis Stokes Cleveland VAMC 2018 - 2019
Committee Member, Radiation Safety Committee, University Hospitals of Cleveland 2015 - 2017
Panel Member, American College of Radiology (ACR) Appopriateness Criteria Expert Panel in Bone Metastasis 2013 - 2020

Professional Memberships

Radiological Society of North America - RSNA
Member
American Society for Radiation Oncology - ASTRO
Member
American Radium Society
Member

External Links

LinkedIn Profilehttps://www.linkedin.com/profile/preview?locale=en_US&trk=prof-0-sb-preview-primary-button
Google Scholarhttps://scholar.google.com/citations?user=y1gB5ZIAAAAJ&hl=en